Comment on “Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?”

Detalles Bibliográficos
Autores principales: Webster, Christopher J., Woollett, Gillian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790339/
https://www.ncbi.nlm.nih.gov/pubmed/31372960
http://dx.doi.org/10.1007/s40259-019-00372-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790339/
https://www.ncbi.nlm.nih.gov/pubmed/31372960
http://dx.doi.org/10.1007/s40259-019-00372-3

Ejemplares similares